A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis

Background. Herein we present our experience with abatacept in a patient diagnosed with primary focal segmental glomerulosclerosis (FSGS) and resistant to steroid and other immunosuppressives. Case. A 17-year-old girl was diagnosed with idiopathic nephrotic syndrome (NS) at the age of 8 years. Kidney biopsy was performed when she did not respond to 6-weeks of steroid (2mg/kg) therapy followed by three doses of pulse methylprednisolone (PMP) and considered as steroid resistant NS. The biopsy revealed focal segmental glomerulosclerosis (FSGS) and cyclophosphamide was added to the steroid treatment but the patient had no response. The genetic analysis revealed G34G/A318A compound homozygous synonym aminoacid variation in NPHS2 gene, thus all immunosuppressive regimes were stopped and she was put on supportive treatment. Throughout this period, she had nephrotic range of proteinuria, however serum albumin levels were >3g/dl. At the end of two years, the patient had NS with severe edema and hypoalbuminemia. When the genetic analysis was interpreted again, it was found to be consistent with a polymorphism rather than a mutation. Following 3 doses of PMP, oral steroid treatment was resumed and cyclosporine (CsA) was added to the treatment at the fifth year of follow up. However, she was unresponsive to CsA at the end of the first year as well as mycophenolate mofetil used for 12 months and rituximab used for 6 months, respectively. Then abatacept was instituted and proteinuria decreased below 1 gr/day and serum albumin levels increased to 3 g/dl at the end of 6 doses. Serum albumin levels remained stable in the following 7 months. Conclusion. Partial remission including the decrease in proteinuria and increase in albumin levels achieved in our patient encourages the usage of abatacept in patients who do not respond to multiple immunosuppressive therapies.

___

1. Bensimhon AR, Williams AE, Gbadegesin RA. Treatment of steroid-resistant nephrotic syndrome in the genomic era. Pediatr Nephrol 2019; 34: 2279- 2293.

2. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003; 362: 629-639.

3. Kemper MJ, Valentin L, van Husen M. Difficult-totreat idiopathic nephrotic syndrome: established drugs, open questions and future options. Pediatr Nephrol 2018; 33: 1641-1649.

4. Jellouli M, Charfi R, Maalej B, Mahfoud A, Trabelsi S, Gargah T. Rituximab in the management of pediatric steroid-resistant nephrotic syndrome: a systematic review. J Pediatr 2018; 197: 191-197.e1.

5. Garin EH, Reiser J, Cara-Fuentes G, et al. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 2015; 30: 469-477.

6. Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2007; 2: 529-542.

7. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A report of the International Study of Kidney Disease in Children. Kidney Int 1981; 20: 765-771.

8. Yu CC, Fornoni A, Weins A, et al. Abatacept in B7- 1-positive proteinuric kidney disease. N Engl J Med 2013; 369: 2416-2423.

9. Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397.

10. Ishimoto T, Shimada M, Gabriela G, et al. Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol Dial Transplant 2013; 28: 1439-1446.

11. Liu Y, Shi Y, Ren R, Xie J, Wang W, Chen N. Advanced therapeutics in focal and segmental glomerulosclerosis. Nephrology (Carlton). 2018; 23(Suppl 4): 57-61.

12. Alachkar N, Carter-Monroe N, Reiser J. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2014; 370: 1263-1264.

13. Delville M, Baye E, Durrbach A, et al. B7-1 blockade does not improve post-transplant nephrotic syndrome caused by recurrent FSGS. J Am Soc Nephrol 2016; 27: 2520-2527.

14. Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? Am J Physiol Renal Physiol 2016; 310: F335-F341.

15. Jayaraman VK, Thomas M. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis. BMJ Case Rep 2016; 2016: 214396.

16. Kamei K, Ishikura K, Sako M, et al; Rituximab for Childhood-Onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab. Pediatr Nephrol 2017; 32: 2071-2078.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

Xanthogranulomatous pyelonephritis due to calculi in a 5-year-old girl

Esra Nagehan AKYOL ÖNDER, Mine ÖZKOL, Nalan NEŞE, Can TANELİ, İpek ÖZÜNAN

Pigeon breeder’s disease as a cause of hypersensitivity pneumonia in children

Ayşe TANA ASLAN, Tuğba ŞİŞMANLAR EYÜBOĞLU, Tuğba RAMASLI GÜRSOY, Zeynep Reyhan ONAY, Öznur BOYUNAĞA

Muscle strength and joint health in children with hemophilia: a cross-sectional study

Necati Muhammed TAT, Ayşe Merve TAT, Filiz CAN, Ahmet Fayik ÖNER

Different clinical presentation in a patient with two novel pathogenic variants of the FBXL4 gene

Engin KÖSE, Melis KÖSE, Zeynep AKIŞIN, Selvinaz EDİZER, Ferah GENEL, Zehra Burcu YILMAZ, Ahmet ŞAHİN

Extracorporeal shock wave lithotripsy in the management of a 14-year-old girl with chronic calcific pancreatitis

Özlem BOYBEYİ TÜRER, TUTKU SOYER, Erkan PARLAK, Hatice NURSUN ÖZCAN, Cenk Yücel BİLEN, Feridun C. TANYEL

Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report

Quanyao CHEN, Zhiyi HUANG, Yao CHEN

Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia

Ga Won JEON, Minji HEO

Pacemaker lead-induced tricuspid stenosis treated with percutaneous valvotomy

Nilüfer ÇETİNER, Işık Yıldırım BAŞTUHAN, Tolga ÖZYİĞİT, Alpay ÇELİKER

Bleeding characteristics and management of minor surgeries in rare bleeding disorders: report from a Turkish Pediatric Hematology Center

Sema AYLAN GELEN, Nazan SARPER, Emine ZENGİN

Circulating Epstein-Barr virus DNA and cell-free DNA in pediatric lymphomas

Bilgehan YALÇIN, Tezer KUTLUK, Serpil KAHRAMAN AĞABABA, Çetin DEMİR, Beril TALİM